Hong Kong-listed biotech stocks surged in early trading, with BeiGene's shares rising by more than 6%.
Hong Kong-listed innovative pharmaceutical concept stocks quickly rose at the beginning of trading, BeiGene surged over 6%, Kanglong Pharmaceutical rose over 5%, WuXi Biologics, Innovent Biologics, and CARsgen Therapeutics all went up.
Latest